Hope on the Horizon: Advances in Pancreatic Cancer

Thursday, September 20, 2018, 12:15 p.m.

In this presentation, Dr. Brandon G. Smaglo, Assistant Professor, Department of Medicine, Hematology-Oncology, Baylor College of Medicine, discusses the current state-of-the-art in pancreatic cancer care. Pancreatic cancer is the third leading cause of cancer-related mortality in the United States.  Pancreatic cancer that is resectable is associated with favorable outcomes. Outcomes for locally advanced, unresectable pancreatic cancer are poor. Determining resectability requires multidisciplinary case review as well as dedicated imaging of the primary tumor. 

Dr. Benjamin Musher, Associate Professor, Department of Medicine, discusses unmet needs and novel treatment options in development for pancreatic cancer. Drs. Musher and Smaglo focus on the novel therapeutics being investigated in clinical trials at BCM’s Dan L. Duncan Comprehensive Cancer Center, including cancer stem cell inhibitors, immune checkpoint inhibitors, and multi-tumor-associated antigen cytotoxic T-lymphocyte therapy. 

CME Information

CME Credit Available

You may claim CME credit after watching this activity.

Needs Statement

Faculty and trainees within the Department of Medicine who are involved in the care of patients need to be regularly updated with the recent advances and guidelines in the fields of medicine and quality improvement to increase clinical knowledge. This Grand Rounds series also aims to provide learners with the appropriate skills to implement the advances and guidelines in clinical practice to enhance the quality of patient care and outcomes.

Objectives

At the conclusion of this activity, the participant should be able to:

  • Provide a brief overview of the staging and treatment of pancreatic cancer.
  • Implement rigorous laboratory and clinical investigation to support efforts to improve outcomes for patients with the most refractory types of cancer.
  • Discuss novel therapeutics for pancreatic cancer, focusing on trials being conducted at Baylor College of Medicine’s Dan L. Duncan Comprehensive Cancer Center.

Target Audience

  • Physicians
  • Medical Students
  • Fellows
  • Residents
  • Nurses
  • Other Health Professionals

Accreditation/Credit Designation

Baylor College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Baylor College of Medicine designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Program Director

Richard J. Hamill, M.D.
Professor
Department of Medicine
Baylor College of Medicine
Houston, Texas
Disclosure: Nothing to disclose.

Term of Approval

August 1, 2019 through August 31, 2021. Original release date: August 1, 2019

Disclosure Policy

The Office of Continuing Medical Education (OCME) makes every effort to develop CME activities that are scientifically based, accurate, current, and objectively presented. In accordance with the Accreditation Council for Continuing Medical Education Standards for Commercial SupportSM, Baylor College of Medicine (BCM) has implemented a mechanism requiring everyone in a position to control the content of an educational activity (e.g., directors, planning committee members, contributors, peer reviewers) to disclose any relevant financial relationships with commercial interests (drug/device companies) and manage/resolve any conflicts of interest prior to the activity. Individuals must disclose to participants the existence or non-existence of financial relationships: 1) at the time of the activity or within 12 months prior; and 2) of their spouses/partners.

Baylor College of Medicine does not view the existence of interests or relationships with commercial entities as implying bias or decreasing the value of a presentation. It is up to the participants to determine whether the interests or relationships influence the presenter with regard to exposition or conclusions.

If at any time during this activity you feel that there has been commercial or promotional bias, please inform us by using the commercial bias comments box in the evaluation form. Please answer the questions about balance in the CME activity evaluation candidly.

Disclosures

The following individual(s) has/have reported financial or other relationship(s) with commercial entities whose products/services may relate to the educational content of this activity:

Presenters

  1. Benjamin Leon Musher, M.D.

    Benjamin Leon Musher, M.D.

    Associate Professor
    Baylor College of Medicine

    Disclosure:

    Nothing to disclose.

  2. Brandon Smaglo, MD, FACP

    Brandon Smaglo, MD, FACP

    Assistant Professor of Internal Medicine (Oncology)
    Baylor College of Medicine

    Disclosure:

    Nothing to disclose.